Senior Management

Søren Bregenholt
CEO
    • Independent in relation to the Company and its management: No
    • Independent in relation to major shareholders: Yes
    • Holdings in Alligator: 1,103,019 shares, 500,000 warrants in program TO 2022/2025 I, 1,200,000 warrants in program TO 2023/2026 I, 900,000 warrants in program TO 2024/2027 I and 194,666 warrants in program TO 9.
    • Other current positions: Chairman of Medicon Valley Alliance, Chairman of A Bioscience Incentive AB and Atlas Therapeutics AB, and Board member of Oblique Therapeutics AB (publ).
    Johan Giléus
    CFO
      • Independent in relation to the Company and its management: No
      • Independent in relation to major shareholders: Yes
      Laura von Schantz
      CTO
        • Independent in relation to the Company and its management: No
        • Independent in relation to major shareholders: Yes
        • Holdings in Alligator: 10,504 shares, 77,000 warrants in program TO 2022/2025 I, and 100,000 warrants in program TO 2024/2027 I.
        • Other current positions: None
        Dr. Sumeet Ambarkhane
        CMO
          • Independent in relation to the Company and its management: No
          • Independent in relation to major shareholders: Yes
          • Holdings in Alligator: 54,205 shares and 250,000 warrants in program TO 2022/2025 I.
          • Other current positions: Inga
          About Alligator
          Board of Directors
          Career
          Updated 2025-01-08
          Cookies
          We use cookies for administering, monitoring and optimizing the website, and for analytical purposes, in accordance with what is stated in our cookie policy.
          Settings Accept all
          Cookies
          Do your settings below. Or read our cookie policy.
          Save Accept all